Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06068491 · ClinicalTrials.gov registry record · NA
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
A NA study of Liver Diseases, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 8
- Study locations
NCT06068491 is a NA study of Liver Diseases that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 450 participants, below the 61,145-participant average among 33 other Liver Diseases trials with a reported enrollment target (99% lower). The trial reports 8 study locations across 5 states.
The verdict
NCT06068491, a NA study of Liver Diseases, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 8
- Study locations
Study Summary
Advanced liver disease is a serious illness that disproportionately affects Veterans, many of whom hope for curative liver transplantation. However, too few receive a transplant and most continue to suffer from increasing symptoms and hospitalizations. The proposed project uses a whole person, Veteran-centered approach that identifies Veterans with advanced liver disease using a population-based health management system and integrates curative and early supportive care using a telemedicine-based nurse care counselor to (1) discuss patient's understanding of illness severity and prognosis, (2) identify priorities and care preferences and (3) align curative and supportive care options to achieve patient priorities. Study outcomes include changes in (1) rates of consideration for liver transplantation, and (2) completion of serious illness discussions. Findings will inform adaptations to the intervention and facilitators for its dissemination.
Conditions Studied
Interventions
- OTHER Vet-CALD
Study Locations (8)
California
- VA Long Beach Healthcare System, Long Beach, CA - Long Beach
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
Texas
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX - Dallas
- Michael E. DeBakey VA Medical Center, Houston, TX - Houston
Arkansas
- Central Arkansas Veterans Healthcare System , Little Rock, AR - Little Rock
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Florida
- Miami VA Healthcare System, Miami, FL - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06068491
The ClinicalTrials.gov registry entry for NCT06068491 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61,145-participant average among 33 other Liver Diseases trials with a reported enrollment target (99% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention - of which Vet-CALD is the first listed.
NCT06068491 reports 8 study locations spanning 5 distinct geographic areas - top geographies include California, Texas, Arkansas.
Frequently Asked Questions
What is clinical trial NCT06068491 about?
NCT06068491 is a clinical study titled "Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)". Advanced liver disease is a serious illness that disproportionately affects Veterans, many of whom hope for curative liver transplantation. However, too few receive a transplant and most continue to suffer from increasing symptoms and hospitalizations. The proposed project uses a whole person, Veter...
What is the current status of trial NCT06068491?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2024-10-01. Estimated completion is 2027-09-30.
What conditions does trial NCT06068491 study?
This clinical trial studies the following conditions: Liver Diseases.
What interventions are being tested in trial NCT06068491?
The interventions under investigation include: Vet-CALD (OTHER).
Who is sponsoring clinical trial NCT06068491?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06068491 being conducted?
This trial has 8 study locations across Arkansas, California, Connecticut, Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
RECRUITING · NA
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
RECRUITING · NA
-
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
RECRUITING · NA
-
Liver Cancer Prevention Randomized Control Trial
ACTIVE NOT RECRUITING · NA
-
Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.